Robin Merkx
Robin Merkx is a PhD candidate in a collaborated project between the department of Urology and the department of Nuclear Medicine. He will work on several pre-clinical and clinical studies concerning girentuximab and clear cell renal cell carcinoma, supervised by Peter Mulders from Urology and Mark Rijpkema from Nuclear Medicine. He started his study Medicine at the Radboud University, Nijmegen in 2011 and graduating in 2018, before that he studied Chemistry at the Radboud University, Nijmegen from 2009 until 2011.